Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2015

01-03-2015 | Images in Metabolic Medicine

Raynaud’s phenomenon associated with Fabry disease

Authors: Dominique P. Germain, Oana I. Atanasiu, Jouda Akrout-Marouene, Karelle Benistan

Published in: Journal of Inherited Metabolic Disease | Issue 2/2015

Login to get access

Excerpt

A 47-year-old man with Fabry disease (p.Asp266Val mutation in the GLA gene) presented with discoloration in the fingertips of both hands (Fig. 1). These symptoms had developed over a period of 7 years. Raynaud’s phenomenon was seen after his hands were exposed to cold. The patient’s history and physical examination revealed no signs or symptoms suggestive of systemic lupus erythematosus or scleroderma and the antinuclear antibody titer was not elevated. Raynaud’s phenomenon is characterized by exaggerated vasoconstrictive color changes (pallor and cyanosis) in the fingers, usually due to exposure to cold. The phenomenon is considered primary if there is no evidence of an underlying medical illness. Secondary Raynaud’s phenomenon occurs in association with another condition, such as systemic lupus erythematosus or scleroderma but has only been reported once in patients with Fabry disease (Wasik et al 2009). Following identification of this case, the presence of Raynaud’s phenomenon was investigated in 207 patients with a confirmed diagnosis of classic Fabry disease followed at our site and 27 additional cases were found, suggesting that Raynaud’s phenomenon may be present in up to 13 % of patients with Fabry disease. Pathogenic mutation of the GLA gene was confirmed in all 28 cases while angiokeratoma and/or evidence of vascular disease were found in some of them (Table 1). Raynaud’s phenomenon further expands the phenotype of the vasculopathy observed in classic Fabry disease.
Table 1
Gender, age, GLA mutation and evidence for angiokeratoma and/or vascular disease in 28 patients with Fabry disease and Raynaud’s phenomenon
Patient #
Gender
Age
GLA mutation
Angiokeratoma (0 = none, 1 = rare, 2 = frequent, 3 = numerous and diffuse)
Evidence of vascular disease (0 = no, 1 = yes)
1
M
62
p.Trp262*
0
1
2
F
27
p.Trp262*
0
0
3
F
42
p.Arg363His
0
0
4
F
47
p.Asp266Val
2
0
5
M
52
p.Asp266Val
1
1
6
M
47
p.Asp266Val
1
0
8
F
63
p.325 fs*9
1
1
9
F
48
p.Cys382Tyrfs*15
2
1
11
F
47
p.Asp266Val
0
1
10
F
68
p.Gly183Asp
1
0
11
M
53
p.Gly163Glufs*2
0
1
12
M
31
p.Arg363Serfs*24
2
0
13
M
59
p.Lys168Asn
1
1
14
F
57
p.Asp264Ala
1
1
15
M
63
P.Trp245*
1
1
16
M
46
p.Gly328Trp
2
1
17
F
60
P.Gly328Trp
0
0
19
F
65
p.Leu403Xfs*1
2
0
20
M
33
p.Asp266Val
2
0
21
F
49
p.Gly373Ser
1
0
22
M
45
p.Ala121Pro
2
1
25
F
35
p.Gly411Asp
1
0
23
M
65
p.Ile198Thr
0
1
24
F
69
p.Arg112Cys
0
1
25
M
50
p.Trp262Leufs*3
2
1
26
F
29
p.Phe50Leu
2
0
27
F
43
p.Arg301Gln
0
0
28
M
60
p.Cys202Trp
1
0
Literature
go back to reference Wasik JS, Simon RW, Meier T, Steinmann B, Amann-Vesti BR (2009) Naifold capillaroscopy: specific features in Fabry disease. Clin Hemorheol Microcirc 42:99–106PubMed Wasik JS, Simon RW, Meier T, Steinmann B, Amann-Vesti BR (2009) Naifold capillaroscopy: specific features in Fabry disease. Clin Hemorheol Microcirc 42:99–106PubMed
Metadata
Title
Raynaud’s phenomenon associated with Fabry disease
Authors
Dominique P. Germain
Oana I. Atanasiu
Jouda Akrout-Marouene
Karelle Benistan
Publication date
01-03-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9799-z

Other articles of this Issue 2/2015

Journal of Inherited Metabolic Disease 2/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.